BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 34132359)

  • 1. Long non‑coding RNA SNHG3 promotes the development of non‑small cell lung cancer via the miR‑1343‑3p/NFIX pathway.
    Zhao L; Song X; Guo Y; Ding N; Wang T; Huang L
    Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34132359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non‑coding RNA LINC01748 exerts carcinogenic effects in non‑small cell lung cancer cell lines by regulating the microRNA‑520a‑5p/HMGA1 axis.
    Tan Y; Xu F; Xu L; Cui J
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34970695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA PSMA3‑AS1 functions as a microRNA‑409‑3p sponge to promote the progression of non‑small cell lung carcinoma by targeting spindlin 1.
    Wang L; Wu L; Pang J
    Oncol Rep; 2020 Oct; 44(4):1550-1560. PubMed ID: 32945481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SNHG3 Promotes Proliferation and Metastasis of Non-Small-Cell Lung Cancer Cells Through miR-515-5p/SUMO2 Axis.
    Li Y; Gao L; Zhang C; Meng J
    Technol Cancer Res Treat; 2021; 20():15330338211019376. PubMed ID: 34032148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non-small-cell lung cancer cells through activating TGF-β pathway and IL-6/JAK2/STAT3 pathway.
    Shi J; Li J; Yang S; Hu X; Chen J; Feng J; Shi T; He Y; Mei Z; He W; Xie J; Li S; Jie Z; Tu S
    J Cell Physiol; 2020 Mar; 235(3):2891-2900. PubMed ID: 31602642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel pathway in NSCLC cells: miR‑191, targeting NFIA, is induced by chronic hypoxia, and promotes cell proliferation and migration.
    Zhao J; Qiao CR; Ding Z; Sheng YL; Li XN; Yang Y; Zhu DY; Zhang CY; Liu DL; Wu K; Zhao S
    Mol Med Rep; 2017 Mar; 15(3):1319-1325. PubMed ID: 28075452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00184 plays an oncogenic role in non-small cell lung cancer via regulation of the miR-524-5p/HMGB2 axis.
    Wang W; Li L; Zhao L
    J Cell Mol Med; 2021 Nov; 25(21):9927-9938. PubMed ID: 34651416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non‑coding RNA PITPNA‑AS1 silencing suppresses proliferation, metastasis and epithelial‑mesenchymal transition in non‑small cell lung cancer cells by targeting microRNA‑32‑5p.
    Chen G; Zheng Z; Li J; Zhang P; Wang Z; Guo S; Ma J; Shen J; Li H
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non‑coding RNA TP73‑AS1 accelerates the progression and cisplatin resistance of non‑small cell lung cancer by upregulating the expression of TRIM29 via competitively targeting microRNA‑34a‑5p.
    Luo S; Shen M; Chen H; Li W; Chen C
    Mol Med Rep; 2020 Nov; 22(5):3822-3832. PubMed ID: 32901838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NORAD regulates epithelial‑mesenchymal transition of non‑small cell lung cancer cells via miR‑422a.
    Chen Z; Che Q; Xie C
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761.
    Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of NEAT1 Suppresses Cell Proliferation, Migration, and Invasion in NSCLC Via Sponging miR-153-3p.
    Zhao L; Bi M; Zhang H; Shi M
    Cancer Biother Radiopharm; 2020 Jun; 35(5):362-370. PubMed ID: 32380843
    [No Abstract]   [Full Text] [Related]  

  • 13. LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR-433-3p to upregulate WTAP.
    Weng L; Qiu K; Gao W; Shi C; Shu F
    BMC Pulm Med; 2020 Aug; 20(1):213. PubMed ID: 32787827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
    Li X; Zheng H
    Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of
    Hu Z; Liu X; Guo J; Zhuo L; Chen Y; Yuan H
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34713294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.
    Yu L; Chen D; Song J
    Thorac Cancer; 2020 Mar; 11(3):603-611. PubMed ID: 31953899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y; Xiao G; Chen Y; Deng Y
    Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of lncRNA SNHG3 Overexpression on Lung Adenocarcinoma by Regulating the Expression of miR-890.
    Kang B; Qiu C; Zhang Y
    J Healthc Eng; 2021; 2021():1643788. PubMed ID: 34306585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non‑coding RNA MEG3 inhibits cell migration and invasion of non‑small cell lung cancer cells by regulating the miR‑21‑5p/PTEN axis.
    Lv D; Bi Q; Li Y; Deng J; Wu N; Hao S; Zhao M
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA SNHG3 promotes breast cancer cell proliferation and metastasis by binding to microRNA-154-3p and activating the notch signaling pathway.
    Jiang H; Li X; Wang W; Dong H
    BMC Cancer; 2020 Sep; 20(1):838. PubMed ID: 32883233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.